ACROBiosystems/Human BCMA / TNFRSF17 Protein, Fc Tag (HPLC verified) DMF Filed/1mg (500ug × 2)/BC7

价格
¥46000.00
货号:BC7
浏览量:127
品牌:ACROBiosystems
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Synonym
    TNFRSF17,CD269,BCM,BCMA
  • Source
    Human BCMA, Fc Tag (HPLC verified) (BC7-H5254) is expressed from human 293 cells (HEK293). It contains AA Met 1 -Ala 54 (Accession # NP_001183.2).
    Predicted N-terminus: Met 1
    Request for sequence
  • Molecular Characterization
    Online(Met 1 -Ala 54) NP_001183.2

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 32.0 kDa. The protein migrates as 34-44 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 0.1 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-HPLC.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 12 months under sterile conditions after reconstitution.
SDS-PAGE
Human BCMA, Fc Tag (HPLC verified) (Cat. No. BC7-H5254) SDS-PAGE gel

Human BCMA, Fc Tag (HPLC verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-HPLC
Human BCMA, Fc Tag (HPLC verified) (Cat. No. ) HPLC images

The purity of Human BCMA, Fc Tag (Cat. No. BC7-H5254) was greater than 90% as determined by SEC-HPLC.

Bioactivity-ELISA
Human BCMA, Fc Tag (HPLC verified)Human BCMA, Fc Tag (HPLC verified) (Cat. No. BC7-H5254) ELISA bioactivity

Immobilized Biotinylated Human BAFF, His,Avitag (Cat. No. BAF-H82Q2) at 1 μg/mL (100 μL/well) on streptavidin precoated (0.2 μg/well) plate, can bind Human BCMA, Fc Tag (Cat. No. BC7-H5254) with a linear range of 0.1-0.8 ng/mL (QC tested).

Protocol
Human BCMA, Fc Tag (HPLC verified)Human BCMA, Fc Tag (HPLC verified) (Cat. No. BC7-H5254) ELISA bioactivity
Report
Human BCMA, Fc Tag (HPLC verified)Human BCMA, Fc Tag (HPLC verified) (Cat. No. BC7-H5254) ELISA bioactivity

Immobilized Human BCMA, Fc Tag (Cat. No. BC7-H5254) at 2 μg/mL (100 μL/well) can bind Anti-Human BCMA Mab with a linear range of 0.1-1.6 ng/mL (Routinely tested).

Protocol
Human BCMA, Fc Tag (HPLC verified)Human BCMA, Fc Tag (HPLC verified) (Cat. No. BC7-H5254) ELISA bioactivity

Immobilized Human APRIL, His,Flag Tag, active trimer (Cat. No. APL-H52D1) at 1 μg/mL (100 μL/well) can bind Human BCMA, Fc Tag (Cat. No. BC7-H5254) with a linear range of 0.1-2 ng/mL (Routinely tested).

Protocol
Bioactivity-BLI
Human_FcRn_Heterodimer_Protein_Bli

Loaded Human APRIL, His,Flag Tag, active trimer (Cat. No. APL-H52D1) on HIS1K Biosensor, can bind Human BCMA, Fc Tag (Cat. No. BC7-H5254) with an affinity constant of 1.88 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
Evaluation of CAR expression
FACS Analysis of Anti-BCMA CAR Expression
Evaluation of CAR expression

293 cells were transfected with anti-BCMA-scFv and RFP tag. 2e5 of the cells were first stained with B. human BCMA / TNFRSF17 protein, Fc tag (Cat. No. BC7-H5254, 3 μg/ml) and C. human Fc tag protein control, followed by FITC-conjugated anti-human IgG Fc antibody. A. Non-transfected 293 cells and C. human Fc tag protein control were used as negative control. RFP was used to evaluate CAR (anti-BCMA-scFv) expression and FITC was used to evaluate the binding activity of human BCMA / TNFRSF17 protein, Fc tag (Cat. No. BC7-H5254).

Protocol
  • Citations
    •  Hypoxia Selectively Impairs CAR-T Cells In Vitro

      Authors: Berahovich R, et al

      Journal: Cancers (Basel) 2019

      Application: Flow Cytometry

      Request for Full-text

    • CAR-T cells based on novel BCMA monoclonal antibody block multiple myeloma cell growth.

      Authors: Berahovich R, et al.

      Journal: Cancers (Basel) 2018

      Application: Flow Cytometry

      Request for Full-text

  • Background
    Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) is also known as B-cell maturation protein (BCMA), CD antigen CD269, which is a member of the TNF-receptor superfamily. TNFRSF17 contains one TNFR-Cys repeat. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. TNFRSF17 is receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B-cell survival and plays a role in the regulation of humoral immunity. TNFRSF17 can activate NF-kappa-B and JNK.
  • References
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

ACROBiosystems治疗性抗体的功效不仅取决于Fab片段及其与靶抗原的结合活性,还取决于Fc片段及其与关键Fc受体的相互作用。Fc片段对FcRn的结合亲和力(FCGRT&B2M)将预测抗体的半衰期,而Fc片段与FcγRIIIa(CD16a)之间的结合亲和力将影响抗体引发ADCC的能力(抗体依赖性细胞介导的细胞毒性)。因此,必须在抗体工程化过程中针对一组受体测试候选人。ACROBiosystems提供了完整的重组Fc受体蛋白集合,包括它们的常见变体,以帮助您加快mAb的开发。